Regeneron Pharmaceuticals, Inc.
Jan 7, 2010

Regeneron Announces Presentation at the 28th Annual J.P. Morgan Healthcare Conference

TARRYTOWN, N.Y., Jan 07, 2010 /PRNewswire via COMTEX News Network/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the 28th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2010. The presentation is scheduled for 1:00 p.m. Eastern Time. The session may be accessed through the Company's web site,, on the Investor Relations page. An archived version of the presentation will be available after the live webcast through February 12, 2010. Additional information about Regeneron and recent news releases are available on the Regeneron web site.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST(R) (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders.

    Contact Information:

    Peter Dworkin                              Laura Lindsay
    Investor Relations                         Media Relations
    914.345.7640                               914.345.7800      

SOURCE Regeneron Pharmaceuticals, Inc.

Copyright (C) 2010 PR Newswire. All rights reserved